Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $122.9M | $85.6M | $87.3M | $110.1M | $158.4M | $124.1M | $97.7M | $85.9M |
| Cost of revenue | $80.4M | $67.1M | $72.2M | $74.5M | $97.0M | $94.4M | $74.3M | $67.1M |
| Gross profit | $42.5M | $18.5M | $15.1M | $35.6M | $61.5M | $29.7M | $23.4M | $18.8M |
| Gross margin | 34.6% | 21.6% | 17.3% | 32.3% | 38.8% | 23.9% | 23.9% | 21.9% |
| R&D | $12.5M | $15.4M | $19.4M | $20.3M | $17.4M | $18.5M | $17.9M | $12.9M |
| Operating income | $7.7M | −$18.3M | −$36.4M | −$9.3M | $9.2M | −$22.5M | −$48.7M | −$26.9M |
| EBITDA | $11.5M | −$12.3M | −$28.8M | −$3.8M | $30.3M | −$39.1M | −$22.4M | −$10.9M |
| Net income | $8.2M | −$17.5M | −$36.0M | −$7.0M | $25.6M | −$24.3M | −$76.4M | −$31.2M |
| Net margin | 6.7% | -20.4% | -41.2% | -6.4% | 16.2% | -19.6% | -78.2% | -36.4% |
| EPS (diluted) | 0.30 | -0.64 | -1.25 | -0.23 | 0.66 | -1.05 | -3.29 | -3.46 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $160M | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds EMKR.
No tracked institution reports a position in EMKR as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-04-02 | 1-for-10reverse |
| 2012-02-16 | 1-for-4reverse |
No one on the platform has traded EMKR yet.
| $38M |
| — |
| NXXTNextNRG Inc. | $0.33 | -2.35% | $41M | — |
| RENNRenren Inc. | $1.65 | -2.94% | $31M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.7× sales vs its 3.8× historical median P/S.
Fair value ≈ $17.13 · price $3.10 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
@judgeyoung2 @ribbey @tonyctl @Trade_the_plan @simon58 @cubie @jenbunn @EBE_day @TraderRapp @lukenight $EMKR
View on StockTwits ↗$APP $HOOD $EMKR to be added to the S&P 500 effective Monday, Sept 22, 2025
View on StockTwits ↗$INTS the last buyout I predicted was $EMKR … think this is next 🚀
View on StockTwits ↗$CNTM I said $EMKR could get bought out and it did, this one I am not even guessing as the offer has been spoken of publicly. No brainer.
View on StockTwits ↗$EMKR When the chart lines up and the whispers start flying… you pay attention. 👀 Twitter whales hinting again... 👇 Setups lookin’ nuclear 🚀 WAKE TF UP 💣 Biotech sleeper heating up — EU revs +33%, 97% accuracy on ColoAlert®, now expanding into pancreatic dx (95%+ early results). Backed by Thermo Fisher & Quest 🧬 FDA catalyst loading 🔄 Volume spiking, whales sniffing 🐋 Float’s razor-thin — setup looks insane. Everything’s pointing to a major breakout next week — volume, sentiment, chart, and upcoming catalysts all lining up 💣📈 This setup doesn’t wait — microfloat’s too tight, and once it moves, it MOVES. No time to snooze — loading now beats chasing later. You’ve been warned. 🚀🔥
View on StockTwits ↗$EMKR Digging EMKR's aerospace pivot. Restructuring looks promising. Merger with Velocity One could be game-changer. Small position building on defense tech potential. compelling writeup: https://beyondspx.com/article/emcore-corporation-nasdaq-emkr-navigating-the-aerospace-and-defense-landscape-with-precision
View on StockTwits ↗$EMKR me sitting here patiently waiting for my buyout tendies
View on StockTwits ↗Wall St is expecting -0.18 EPS for $EMKR Q1 [Reporting 02/19 AMC] http://www.estimize.com/intro/emkr?chart=historical&metric_name=eps&utm_c
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.